“The Canadian and Chinese scientists would collaborate on the trials, which would include about 1,000 test patients. Chrétien and Mbikay plan to join colleagues from the non-profit International Consortium of Antivirals — which Chrétien co-founded with Jeremy Carver in 2004 as a response to the SARS epidemic — in manning a 24/7 communications centre as soon as clinical trials go ahead.

There’s also a study looking at serum obtained from patients who recovered from laboratory confirmed COVID-19 infection — the idea being that it will contain antibodies a freshly-infected patient would need to fight off the infection more effectively.



Read more…